FDA Lapse in Funding
In the absence of either an FY 2019 appropriation or a Continuing Resolution for FDA, beginning on December 22, 2018 and continuing until the date of enactment of an FY 2019 appropriation or Continuing Resolution ("lapse period"), agency operations continue to the extent permitted by law, such as activities necessary to address imminent threats to the safety of human life and activities funded by carryover user fee funds. Read more
New Information for FDA Employees
If you are an FDA employee with a question about the current lapse in appropriations funding, please email AskFDA2019@fda.hhs.gov. Depending on your furlough status please continue to monitor insideFDA or FDA.gov for available information on the current lapse in appropriations funding for the FDA. More information for employees
- Medications, homeopathic remedies and teething jewelry can be dangerous.
- Supporting and understanding the patient experience and incorporating patient feedback into our work is an agency-wide priority.
- How much do you know about that cup of coffee you drink each morning? There may be more to it than you think.
News & Events
- January 15, 2019 - Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies
- January 07, 2019 - Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s new actions under the Pre-Cert Pilot Program to promote a more efficient framework for the review of safe and effective digital health innovations
- December 21, 2018 - FDA permits marketing of a diagnostic test to aid in measuring nutrients in breast milk
Recent Consumer Updates
Browse by Audience
Updates and information for staying safe and healthy
Learn about other treatments, drug/device approvals, public meetings and more
For Health Professionals
Medical product safety information, adverse event/problem reporting and more
For Scientists & Researchers
NCTR, pediatrics, clinical trials, Critical Path Initiative, foods and veterinary medicine research, and more
Guidance, registration and listing, pay user fees, import programs and more
Perspectives from FDA Experts
January 9, 2019
The Future of FDA's Electronic Safety Surveillance